These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 12402286

  • 21. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, Engvall E, Müller U, Ruegg MA.
    Nature; 2001 Sep 20; 413(6853):302-7. PubMed ID: 11565031
    [Abstract] [Full Text] [Related]

  • 22. [Severe childhood autosomal recessive muscular dystrophy].
    Matsumura K, Shimizu T.
    Rinsho Shinkeigaku; 1995 Dec 20; 35(12):1422-4. PubMed ID: 8752417
    [Abstract] [Full Text] [Related]

  • 23. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
    Cullen MJ, Walsh J, Roberds SL, Campbell KP.
    Neuropathol Appl Neurobiol; 1996 Feb 20; 22(1):30-7. PubMed ID: 8866780
    [Abstract] [Full Text] [Related]

  • 24. Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane.
    Li X, Talts U, Talts JF, Arman E, Ekblom P, Lonai P.
    Proc Natl Acad Sci U S A; 2001 Dec 04; 98(25):14416-21. PubMed ID: 11734644
    [Abstract] [Full Text] [Related]

  • 25. Temporal and spatial appearance of alpha-dystroglycan in differentiated mouse myoblasts in culture.
    Kostrominova TY, Tanzer ML.
    J Cell Biochem; 1995 Aug 04; 58(4):527-34. PubMed ID: 7593275
    [Abstract] [Full Text] [Related]

  • 26. Laminin-α1 LG4-5 domain binding to dystroglycan mediates muscle cell survival, growth, and the AP-1 and NF-κB transcription factors but also has adverse effects.
    Zhou YW, Munoz J, Jiang D, Jarrett HW.
    Am J Physiol Cell Physiol; 2012 Mar 15; 302(6):C902-14. PubMed ID: 22159078
    [Abstract] [Full Text] [Related]

  • 27. Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin.
    Higuchi I, Yamada H, Fukunaga H, Iwaki H, Okubo R, Nakagawa M, Osame M, Roberds SL, Shimizu T, Campbell KP.
    J Clin Invest; 1994 Aug 15; 94(2):601-6. PubMed ID: 8040315
    [Abstract] [Full Text] [Related]

  • 28. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
    Handa V, Mital A, Gupta M, Goyle S.
    Neurol India; 2001 Mar 15; 49(1):19-24. PubMed ID: 11303236
    [Abstract] [Full Text] [Related]

  • 29. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction.
    Brown SC, Fassati A, Popplewell L, Page AM, Henry MD, Campbell KP, Dickson G.
    J Cell Sci; 1999 Jan 15; 112 ( Pt 2)():209-16. PubMed ID: 9858474
    [Abstract] [Full Text] [Related]

  • 30. Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.
    Rando TA.
    Microsc Res Tech; 2001 Nov 15; 55(4):223-35. PubMed ID: 11748861
    [Abstract] [Full Text] [Related]

  • 31. Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis.
    Durbeej M, Jung D, Hjalt T, Campbell KP, Ekblom P.
    Dev Biol; 1997 Jan 15; 181(2):156-67. PubMed ID: 9013927
    [Abstract] [Full Text] [Related]

  • 32. Decreased expression of brain beta-dystroglycan in Duchenne muscular dystrophy but not in the mdx animal model.
    Finn DM, Culligan KG, Ohlendieck K.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):231-5. PubMed ID: 9705863
    [Abstract] [Full Text] [Related]

  • 33. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M, Suel L, Barbet JP, Beckmann JS, Fougerousse F.
    Morphologie; 2002 Jun 10; 86(273):9-12. PubMed ID: 12224393
    [Abstract] [Full Text] [Related]

  • 34. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.
    Chung W, Campanelli JT.
    Mol Cell Biol Res Commun; 1999 Jun 10; 2(3):162-71. PubMed ID: 10662592
    [Abstract] [Full Text] [Related]

  • 35. Eye muscle sparing by the muscular dystrophies: lessons to be learned?
    Andrade FH, Porter JD, Kaminski HJ.
    Microsc Res Tech; 1999 Jun 10; 48(3-4):192-203. PubMed ID: 10679966
    [Abstract] [Full Text] [Related]

  • 36. Utrophin-dystroglycan complex in membranes of adherent cultured cells.
    James M, Nguyen TM, Wise CJ, Jones GE, Morris GE.
    Cell Motil Cytoskeleton; 1996 Jun 10; 33(3):163-74. PubMed ID: 8674136
    [Abstract] [Full Text] [Related]

  • 37. Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development.
    Masaki T, Matsumura K, Hirata A, Yamada H, Hase A, Arai K, Shimizu T, Yorifuji H, Motoyoshi K, Kamakura K.
    Exp Neurol; 2002 Mar 10; 174(1):109-17. PubMed ID: 11869039
    [Abstract] [Full Text] [Related]

  • 38. Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos.
    Parsons MJ, Campos I, Hirst EM, Stemple DL.
    Development; 2002 Jul 10; 129(14):3505-12. PubMed ID: 12091319
    [Abstract] [Full Text] [Related]

  • 39. The dynamics of dystroglycan.
    Chamberlain J.
    Nat Genet; 1999 Nov 10; 23(3):256-8. PubMed ID: 10545934
    [No Abstract] [Full Text] [Related]

  • 40. Stent implantation activates Akt in the vessel wall: role of mechanical stretch in vascular smooth muscle cells.
    Zhou RH, Lee TS, Tsou TC, Rannou F, Li YS, Chien S, Shyy JY.
    Arterioscler Thromb Vasc Biol; 2003 Nov 01; 23(11):2015-20. PubMed ID: 12969991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.